Market positioning Target biopharma and medtech firms seeking specialized launch and commercialization support, with existing engagement among top global pharma customers indicating high credibility and potential for upsell advisory services like market access, pricing strategy, and lifecycle management.

Global footprint Leverage Switzerland, UK and US presence to offer cross-border market access projects, regional regulatory strategy, and global launch execution services for multinational clients expanding or harmonizing their global strategies.

Leadership visibility Promotions and partner-level leadership (e.g., recent partner appointment) present opportunities to position executive sponsorships, capability demonstrations, and case-led discussions around high-stakes programs to prospective pharma clients.

Diversity leverage Diverse, multi-national team with 21 nationalities and strong DEI credentials can be marketed to clients prioritizing inclusive global market strategies and patient access programs, potentially opening opportunities in patient-centric access and real-world evidence projects.

Recognition signals Recent industry recognition as a top 25 EMEA consulting firm can be used in outreach to large pharma targets seeking trusted partners for strategic advisory, with a focus on expansion into EMEA and alignment on complex market access and commercialization milestones.